Research ExplorerPublicationsManagement of Coagulopathy during Bleeding and Invasive Proc...

Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure

Standard

Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure. / Drolz, Andreas; Ferlitsch, Arnulf; Fuhrmann, Valentin.

In: VISC MED, Vol. 34, No. 4, 08.2018, p. 254-258.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Drolz, A, Ferlitsch, A & Fuhrmann, V 2018, 'Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure', VISC MED, vol. 34, no. 4, pp. 254-258. https://doi.org/10.1159/000491106

APA

Drolz, A., Ferlitsch, A., & Fuhrmann, V. (2018). Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure. VISC MED, 34(4), 254-258. https://doi.org/10.1159/000491106

Vancouver

Drolz A, Ferlitsch A, Fuhrmann V. Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure. VISC MED. 2018 Aug;34(4):254-258. https://doi.org/10.1159/000491106

Bibtex

@article{ca4327d1600d4dd78068e151c0c1d11d,
title = "Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure",
abstract = "Alterations in hemostasis are a characteristic feature of advanced liver disease. Patients with coagulopathy of advanced liver disease are prone to bleedings and also thromboembolic events. Under stable conditions, cirrhosis patients show alterations in both pro- and anticoagulatory pathways, frequently resulting in a rebalanced hemostasis. This review summarizes current recommendations of management during bleeding and prior to invasive procedures in patients with cirrhosis.",
keywords = "Journal Article, Review",
author = "Andreas Drolz and Arnulf Ferlitsch and Valentin Fuhrmann",
year = "2018",
month = aug,
doi = "10.1159/000491106",
language = "English",
volume = "34",
pages = "254--258",
journal = "VISC MED",
issn = "2297-4725",
publisher = "S. Karger AG",
number = "4",

}

RIS

TY - JOUR

T1 - Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure

AU - Drolz, Andreas

AU - Ferlitsch, Arnulf

AU - Fuhrmann, Valentin

PY - 2018/8

Y1 - 2018/8

N2 - Alterations in hemostasis are a characteristic feature of advanced liver disease. Patients with coagulopathy of advanced liver disease are prone to bleedings and also thromboembolic events. Under stable conditions, cirrhosis patients show alterations in both pro- and anticoagulatory pathways, frequently resulting in a rebalanced hemostasis. This review summarizes current recommendations of management during bleeding and prior to invasive procedures in patients with cirrhosis.

AB - Alterations in hemostasis are a characteristic feature of advanced liver disease. Patients with coagulopathy of advanced liver disease are prone to bleedings and also thromboembolic events. Under stable conditions, cirrhosis patients show alterations in both pro- and anticoagulatory pathways, frequently resulting in a rebalanced hemostasis. This review summarizes current recommendations of management during bleeding and prior to invasive procedures in patients with cirrhosis.

KW - Journal Article

KW - Review

U2 - 10.1159/000491106

DO - 10.1159/000491106

M3 - SCORING: Review article

C2 - 30345282

VL - 34

SP - 254

EP - 258

JO - VISC MED

JF - VISC MED

SN - 2297-4725

IS - 4

ER -